ID   Hepa1c1c7-MP
AC   CVCL_DC14
DR   Wikidata; Q54882827
RX   Patent=US20050277142;
CC   Group: Patented cell line.
CC   Registration: Bioresource Collection and Research Center (BCRC) of Taiwan; BCRC 960207.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6089.
CC   Biotechnology: Can be used for bioassays to detect dioxin/TCDD-like compounds.
CC   Characteristics: Acts through the activation of a luciferase reporter gene which is under the control of dioxin-response elements (DREs) from mouse Cyp1a1 gene.
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
RX   Patent=US20050277142;
RA   Lee W.-S., Lee H.-Y., Chang-Chien G.-P., Huang Y.-W., Lu K.-Y.;
RT   "Recombinant cell line for the detection of dioxin-like compounds
RT   based on the expression of luciferase gene.";
RL   Patent number US20050277142, 15-Dec-2005.
//